Abacavir
Active pharmaceutical substance formulated in Jan Aushadhi generic products for Antibiotics & Anti-Infectives treatment.
🧴 Clinical Application
Take orally once daily or twice daily at the exact same hour every single day. Strict lifelong adherence is paramount to prevent viral rebound and resistance mutation. Do not skip doses or alter timing without specialist guidance.
⚠️ Side Effects
Common: Headache, nausea, fatigue, insomnia, diarrhea, abnormal dreams (with efavirenz). Rare/Severe: Renal tubular dysfunction/Fanconi syndrome (tenofovir disoproxil), loss of bone mineral density, severe hypersensitivity (abacavir HLA-B*5701), lactic acidosis/severe hepatomegaly with steatosis, and immune reconstitution inflammatory syndrome (IRIS).
🛡️ Safety Warnings
Black box warnings: Exacerbation of Hepatitis B upon treatment discontinuation in co-infected patients. HLA-B*5701 genetic testing is mandatory prior to abacavir administration to prevent fatal hypersensitivity. Routine monitoring of renal function, bone density, viral load, and CD4 counts is essential.
Jan Aushadhi Products containing Abacavir
Found 2 generic formulation(s) containing this active ingredient.
Abacavir 600mg + Dolutegravir 50mg + Lamivudine 300mg Tablets
Antiretroviral therapy (ART) formulation comprising nucleotide/nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), integrase strand transfer inhibitors (INSTIs), or boosted protease inhibitors (PIs). Engineered to suppress HIV-1 viral replication to undetectable levels, halt disease progression, and restore CD4 immune function.
Abacavir 600mg + Lamivudine 300mg Tablets
Antiretroviral therapy (ART) formulation comprising nucleotide/nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), integrase strand transfer inhibitors (INSTIs), or boosted protease inhibitors (PIs). Engineered to suppress HIV-1 viral replication to undetectable levels, halt disease progression, and restore CD4 immune function.
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Abacavir.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Abacavir 600mg + Dolutegravir 50mg + Lamivudine 300mg Tablets | 30's Bottle | ₹2718.75 | INBEC | ₹5249.56 | 48% Save |
| Abacavir 600mg + Lamivudine 300mg Tablets | 30's Bottle | ₹953.91 | ABEC | ₹2201.81 | 57% Save |
Frequently Asked Questions (FAQ)
Get answers to common queries about Abacavir generics.